Morning plenary

09:00 – 09:30: Check-in and welcome coffee

09:30 – 09:45: Welcome by Ann Van Gysel, MEDVIA and Xavier Hormaechea, Biowin

Keynote session

09:45 – 10:15: Where technology and biology meet, Jan Rabaey, University of California at Berkeley, imec

Showcasing Innovative Treatment And Prevention Platforms

10:15 – 10:45: Bioconvergence: joining forces between biology, engineering, nanotech & IT, Peter Peumans, imec

10:45 – 11:15: Networking coffee break & exhibition

11:15 – 11:45: Spatial and computational biology, Thierry Voet, KU Leuven and Martin Guilliams, UGent

11:45 – 12:15: Immunology and prevention of infectious diseases, Emmanuel Hanon, Vicebio 

12:15 – 13:30: Networking lunch

Afternoon breakout sessions

Biopharmaceutical engineering / manufacturing

13:30- 13:45: Setting the scene by Thomas De Beer, CESPE

13:45 – 14:00: Nico Callewaert,VIB

14:00 – 14:15: Hugues Bultot, Univercells

14:15-14:30: Veronika Nindl, VTU

(Digital) technology / diagnostic tools (biomarkers)

13:30- 13:45: Setting the scene by Jean-Luc Balligand, UCL

13:45-14:00: Joris WalraevensByteflies

14:00-14:15: Niels Vandervoort, Janssen Pharmaceutica

14:15-14:30: Tim Dieryckx, Voxdale

14:30-14:50: Networking coffee break & exhibition

Afternoon plenary

14:50 – 15:00:  Welcome (afternoon program), Jan Van der Goten, HST

Keynote session

15:00 – 15:30: Data and technology transforming patient population stratification, Brett Beaulieu-Jones, University of Chicago

Round Table

15:30 – 16:30: Roundtable

Building a leading health & biopharma valley. 

We stand at the intersection of merging technology and biology, and this conference serves as a testament to the successes that this collaborative approach has already achieved and will continue to bring.

The round table discussion aims to explore vital steps and strategies for establishing Belgium as a prominent region. Focusing on key technologies like ATMP, digital health, and radiotherapy, the panel delves into challenges, opportunities, and best practices. Drawing on both local and international experiences, the discussion underscores the significance of collaborative efforts in addressing these challenges.


  • Ann Van Gysel, MEDVIA
  • Jan Van Der Goten, HST
  • Pieter Sauwens, Deloitte
  • Peter Peumans, imec
  • Koen Hasaers, SCK CEN
  • BioWin representative

Moderated by Ingrid Maes.

Closing Keynote

16:30 – 17:00: Sofie De Bock, Microsoft

17:00 – 17:15: Closing and invite for reception, MEDVIA & Biowin

Science for health is a joint organization from

With the support of following partners

Stay up-to-date

Sign up for our newsletter and be the first to receive information on our next edition.